The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells <i>In Vitro</i> and <i>In Vivo</i>

Keun‐Yong Eom(Seoul National University), In Ah Kim(Seoul National University)
Cancer Research and Treatment
June 8, 2015
Cited by 31


Related Papers